CURRENT ISSUE Current Issue Cover
VOL 8 • NO 6 SEP/OCT 2017
IN THIS ISSUE

Breast Implants and Lymphoma: What Is the Risk for Your Patient?

Pamela Hallquist Viale, RN, MS, CNS, ANP

Assessing the Plain Language Planner for Communication About Common Palliative Care Medications

Elaine Wittenberg,(1) PhD, Betty Ferrell,(2) RN, PhD, MA, FAAN, FPCN, CHPN, and Joy Goldsmith,(3) PhD


Managing Drug Interactions in Cancer Therapy: A Guide for the Advanced Practitioner

Christopher J. Campen,(1) PharmD, BCOP, Wendy H. Vogel,(2) MSN, FNP, AOCNP®, and Pooja J. Shah,(3) PharmD, BCPS

 
Section Seperator

TODAY'S NEWS

Olaparib Receives Positive pCODR Recomme...

The pan-Canadian Oncology Drug Review (pCODR) has ...

Durvalumab Consolidation After Chemoradi...

As reported by Antonia et al in The New England Jo...

Adjuvant Nivolumab vs Ipilimumab in Rese...

The phase III Checkmate 238 trial has shown improv...

Preexisting Dementia and Survival in Old...

A pre-existing diagnosis of dementia was associate...

Tibetan Yoga Practice May Improve Sleep ...

Participating in twice-weekly practice of Tibetan ...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Brentuximab Vedotin Infusion Reaction

Infusion reactions have been reported with brentuximab vedotin therapy in both clinical trial settings and in the post clinical trial experience...

Patients Receiving Inotuzumab Ozogamicin

Successfully conducting oncology clinical trials requires the involvement of various research personnel...

Screening for Cancer w/Prostate-Specific Antigen

Prostate cancer is the second-leading cause of cancer death in male Americans, behind only lung cancer...

Venetoclax for Patients With del(17p) CLL

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by abnormal numbers of mature B lymphocytes...

The Oncology Care Model for APs

The Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) is a new, multipayer model that focuses on higher quality, coordinated oncology care...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Positive Results from Phase III MURANO T...

The phase III MURANO study of venetoclax tablets i...

Overall Survival With Nivolumab/Ipilimum...

Overall survival outcomes in the phase III CheckMa...

Surgeon-Initiated Gene-Expression Profil...

In a single-center study reported in the <em>...

Assessing and Managing CAR T-Cell Treatm...

Immune-cell based therapies opening a new frontier...

AACR Releases 2017 Cancer Progress Repor...

Federally funded research that provides a deep und...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me